Market Tracker

01/30 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.28
Data as of Jan 30
 -0.04 / -3.03%
Today’s Change
1.27
Today|||52-Week Range
3.18
-7.91%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.32
Today’s open1.30
Day’s range1.28 - 1.33
Volume843,793
Average volume (3 months)873,976
Market cap$240.3M
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-27.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales10.03
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc-0.29-2.86%
CNCEConcert Pharmaceutic...-0.15-1.12%
HRTXHeron Therapeutics I...-0.46-5.50%
CPRXCatalyst Pharmaceuti...+0.23+6.73%
Data as of 3:59pm ET, 01/30/2015

Financials

Next reporting dateMarch 6, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts